Atlantic Equities Upgrades Abbott Laboratories to Overweight, Announces $144 Price Target
Atlantic Equities analyst James Mainwaring upgrades Abbott Laboratories (NYSE:ABT) from Neutral to Overweight and announces $144 price target.
Kimberly-Clark’s Earnings Remind Investors that Inflation and Supply Chain Issues are Still a Major Theme
This week is a big one for earnings, not just because of the big names reporting but because of the large number of earnings announcements. Investors can expect the themes of higher costs and supply chain issues to continue.
A-List Executive Team, Big-Name Backers Fail to Lift Abbisko IPO
Key takeaways
Four rounds of fundraising together with IPO proceeds have given the Abbisko a cumulative war chest of almost $500 million
Company is betting a significant portion of its funds on China rights to an AstraZeneca drug to treat multiple solid tumors
By Richard Barbarossa
10 Biggest Price Target Changes For Thursday
Wedbush boosted Tesla, Inc. (NASDAQ: TSLA) price target from $1,000 to $1,100. Tesla shares fell 1.4% to $853.67 in pre-market trading.
Abbot Labs and Biogen Outshine Novavax in the Health Care Sector
Just before Tuesday’s close, Netflix (NASDAQ: NFLX) reported better-than-expected earnings by adding 4.4 million subscribers in the third quarter.
Why Abbott Shares Are Rising Today
Abbott Laboratories (NYSE: ABT) is trading higher Wednesday after the company announced better-than-expected third-quarter financial results and raised guidance.
Abbott’s Q3 Profit Jumps 70% On Robust COVID-19 Test Sales
Abbott Laboratories (NYSE:ABT) reported a 70.5% rise in quarterly profit to $2.1 billion, helped by strength in its medical devices and…
The Daily Biotech Pulse: Novavax Retreats Amid Vaccine Issues, LumiraDx COVID Test Approved In India, Sesen Shines On Positive Bladder Cancer Review
Here's a roundup of top developments in the biotech space over the last 24 hours.
5 Stocks To Watch For October 20, 2021
Some of the stocks that may grab investor focus today are:
Wall Street expects Verizon Communications Inc. (NYSE: VZ) to report quarterly earnings at $1.36 per share on revenue of $33.28 billion before the opening bell. Verizon shares gained 0.5% to $52.62 in after-hours trading.